Intro offer
100 days of Premium for just $10.
Try all Premium features for over 3 months and analyze stocks without limits.
Try 100 days for $10

$75.46
0.26%
NYSE, Sep 17, 09:51 am EDT. Market open.
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Target price 2026 - Analyst rating & recommendation

Globus Medical, Inc. Class A Classifications & Recommendation

Buy
70%
Hold
30%

Globus Medical, Inc. Class A Price Target

Target Price $102.00
Price $75.26
Potential
Number of Estimates 17
17 Analysts have issued a price target Globus Medical, Inc. Class A 2027 . The average Globus Medical, Inc. Class A target price is $102.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 16 Analysts recommend Globus Medical, Inc. Class A to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Globus Medical, Inc. Class A stock has an average upside potential 2027 of . Most analysts recommend the Globus Medical, Inc. Class A stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 2.94 3.26
16.65% 11.06%
EBITDA Margin 22.32% 34.07%
62.99% 52.66%
Net Margin 18.30% 20.98%
347.74% 14.64%

19 Analysts have issued a sales forecast Globus Medical, Inc. Class A 2026 . The average Globus Medical, Inc. Class A sales estimate is

$3.3b
unlock
. This is
3.79% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.4b 7.38%
unlock
, the lowest is
$3.1b 0.86%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.9b 16.65%
2026
$3.3b 11.06%
unlock
2027
$3.5b 6.00%
unlock
2028
$3.7b 6.10%
unlock
2029
$4.1b 11.44%
unlock
2030
$4.4b 7.97%
unlock

17 Analysts have issued an Globus Medical, Inc. Class A EBITDA forecast 2026. The average Globus Medical, Inc. Class A EBITDA estimate is

$1.1b
unlock
. This is
40.39% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.2b 49.48%
unlock
, the lowest is
$1.0b 28.78%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $656m 90.13%
2026
$1.1b 69.54%
unlock
2027
$1.2b 8.54%
unlock
2028
$1.3b 7.37%
unlock
2029
$1.5b 14.89%
unlock
2030
$1.7b 12.56%
unlock

EBITDA Margin

2025 22.32% 62.99%
2026
34.07% 52.66%
unlock
2027
34.88% 2.38%
unlock
2028
35.30% 1.20%
unlock
2029
36.40% 3.12%
unlock
2030
37.94% 4.23%
unlock

18 Globus Medical, Inc. Class A Analysts have issued a net profit forecast 2026. The average Globus Medical, Inc. Class A net profit estimate is

$685m
unlock
. This is
27.89% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$712m 32.95%
unlock
, the lowest is
$654m 22.12%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $538m 422.31%
2026
$685m 27.31%
unlock
2027
$739m 7.94%
unlock
2028
$803m 8.60%
unlock
2029
$902m 12.42%
unlock
2030
$1.0b 13.20%
unlock

Net Margin

2025 18.30% 347.74%
2026
20.98% 14.64%
unlock
2027
21.36% 1.81%
unlock
2028
21.87% 2.39%
unlock
2029
22.06% 0.87%
unlock
2030
23.13% 4.85%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 3.92 5.10
422.67% 30.10%
P/E 14.75
EV/Sales 2.91

18 Analysts have issued a Globus Medical, Inc. Class A forecast for earnings per share. The average Globus Medical, Inc. Class A EPS is

$5.10
unlock
. This is
30.43% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$5.30 35.55%
unlock
, the lowest is
$4.87 24.55%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $3.92 422.67%
2026
$5.10 30.10%
unlock
2027
$5.51 8.04%
unlock
2028
$5.98 8.53%
unlock
2029
$6.72 12.37%
unlock
2030
$7.61 13.24%
unlock

P/E ratio

Current 19.25 14.47%
2026
14.75 23.37%
unlock
2027
13.67 7.32%
unlock
2028
12.59 7.90%
unlock
2029
11.20 11.04%
unlock
2030
9.89 11.70%
unlock

Based on analysts' sales estimates for 2026, the Globus Medical, Inc. Class A stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.02 3.07%
2026
2.91 3.52%
unlock
2027
2.75 5.66%
unlock
2028
2.59 5.75%
unlock
2029
2.32 10.27%
unlock
2030
2.15 7.38%
unlock

P/S ratio

Current 3.21 6.38%
2026
3.10 3.65%
unlock
2027
2.92 5.67%
unlock
2028
2.75 5.75%
unlock
2029
2.47 10.27%
unlock
2030
2.29 7.38%
unlock

Current Globus Medical, Inc. Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Aug 07 2026
UBS
Locked
Locked
Locked Jul 28 2026
Truist Securities
Locked
Locked
Locked Jul 16 2026
RBC Capital
Locked
Locked
Locked Jul 13 2026
BMO Capital
Locked
Locked
Locked Jul 09 2026
Stifel
Locked
Locked
Locked Jul 08 2026
Piper Sandler
Locked
Locked
Locked Jun 15 2026
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Aug 07 2026
Locked
UBS:
Locked
Locked
Jul 28 2026
Locked
Truist Securities:
Locked
Locked
Jul 16 2026
Locked
RBC Capital:
Locked
Locked
Jul 13 2026
Locked
BMO Capital:
Locked
Locked
Jul 09 2026
Locked
Stifel:
Locked
Locked
Jul 08 2026
Locked
Piper Sandler:
Locked
Locked
Jun 15 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today